✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

MoonLake Immunotherapeutics

Country
Switzerland
Sector
Healthcare
Industry
Biotechnology
Employees
130
Ticker
MLTX
Exchange
NASDAQ, INC.
Description
MoonLake Immunotherapeutics Class A Ordinary Shares represent ownership in MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on therapies for inflammatory skin and joint dise...

MoonLake Immunotherapeutics's Revenues Data

Explore MoonLake Immunotherapeutics's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
0a
0a
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind MoonLake Immunotherapeutics’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. MoonLake Immunotherapeutics's 10-K 2025